NO20021135L - Monomere analoger av human insulin - Google Patents

Monomere analoger av human insulin

Info

Publication number
NO20021135L
NO20021135L NO20021135A NO20021135A NO20021135L NO 20021135 L NO20021135 L NO 20021135L NO 20021135 A NO20021135 A NO 20021135A NO 20021135 A NO20021135 A NO 20021135A NO 20021135 L NO20021135 L NO 20021135L
Authority
NO
Norway
Prior art keywords
human insulin
monomer analogs
analogs
monomer
insulin
Prior art date
Application number
NO20021135A
Other languages
English (en)
Other versions
NO20021135D0 (no
Inventor
You-Min Feng
You-Shang Zhang
Original Assignee
Shanghai Inst Biochemistry
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Inst Biochemistry filed Critical Shanghai Inst Biochemistry
Publication of NO20021135L publication Critical patent/NO20021135L/no
Publication of NO20021135D0 publication Critical patent/NO20021135D0/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/62Insulins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
NO20021135A 1999-09-08 2002-03-07 Monomere analoger av human insulin NO20021135D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN99116851A CN1125081C (zh) 1999-09-08 1999-09-08 重组天然和新型人胰岛素及其制备方法
PCT/GB2000/003460 WO2001018052A1 (en) 1999-09-08 2000-09-08 Monomeric analogues of human insulin

Publications (2)

Publication Number Publication Date
NO20021135L true NO20021135L (no) 2002-03-07
NO20021135D0 NO20021135D0 (no) 2002-03-07

Family

ID=5279521

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20021135A NO20021135D0 (no) 1999-09-08 2002-03-07 Monomere analoger av human insulin

Country Status (15)

Country Link
US (1) US6800606B1 (no)
EP (1) EP1210369A1 (no)
JP (1) JP2003525867A (no)
CN (1) CN1125081C (no)
AU (1) AU767006B2 (no)
BR (1) BR0013840A (no)
CA (1) CA2383638A1 (no)
CZ (1) CZ20021227A3 (no)
HU (1) HUP0202793A3 (no)
IL (1) IL148380A0 (no)
MX (1) MXPA02002489A (no)
NO (1) NO20021135D0 (no)
PL (1) PL354488A1 (no)
TR (1) TR200200599T2 (no)
WO (1) WO2001018052A1 (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR025646A1 (es) * 2000-09-13 2002-12-04 Beta Lab Sa Cepa de levaduras metilotroficas recombinantes productoras de un precursor de insulina, construcciones de adn y metodo para obtener la cepa.
US7833513B2 (en) 2004-12-03 2010-11-16 Rhode Island Hospital Treatment of Alzheimer's Disease
WO2013144685A1 (en) 2012-03-29 2013-10-03 Biocon Limited Secretion of functional insulin glargine directly into the culture medium through over expression of kex2p intracellularly
CN102703552B (zh) * 2012-05-15 2014-10-29 山东阿华生物药业有限公司 重组人胰岛素的制备方法及其产品
CN102816819B (zh) * 2012-08-13 2014-10-29 山东阿华生物药业有限公司 提高人胰岛素前体融合蛋白酶切转换成b30缺苏氨酸人胰岛素产率的方法
JP7170332B2 (ja) * 2016-12-09 2022-11-14 アクストン バイオサイエンシズ コーポレーション インスリンとfcの融合物および使用方法
CN113166198A (zh) 2018-08-20 2021-07-23 拜康生物制品有限公司 用于纯化胰岛素类似物的色谱方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3033127A1 (de) * 1980-09-03 1982-04-08 Hoechst Ag, 6000 Frankfurt Neue analoga des insulins
DK58285D0 (da) 1984-05-30 1985-02-08 Novo Industri As Peptider samt fremstilling og anvendelse deraf
PH25772A (en) 1985-08-30 1991-10-18 Novo Industri As Insulin analogues, process for their preparation
DE3717370A1 (de) * 1987-05-22 1988-12-01 Hoechst Ag Mischkristalle aus insulin und insulinderivaten, verfahren zur herstellung dieser mischkristalle, diese mischkristalle enthaltende pharmazeutische mittel und ihre verwendung zur behandlung von diabetes mellitus
NZ232375A (en) * 1989-02-09 1992-04-28 Lilly Co Eli Insulin analogues modified at b29
PL310007A1 (en) * 1992-12-18 1995-11-13 Lilly Co Eli Insulin analogues
CN1044856C (zh) 1993-10-19 1999-09-01 中国科学院上海有机化学研究所 果聚糖同系混合物的药物、生产方法及其用途
YU18596A (sh) 1995-03-31 1998-07-10 Eli Lilly And Company Analogne formulacije monomernog insulina
WO1999042482A1 (en) * 1998-02-23 1999-08-26 Neurocrine Biosciences, Inc. Methods for treatment of diabetes using peptide analogues of insulin

Also Published As

Publication number Publication date
PL354488A1 (en) 2004-01-26
TR200200599T2 (tr) 2002-05-21
MXPA02002489A (es) 2002-08-28
AU767006B2 (en) 2003-10-30
IL148380A0 (en) 2002-09-12
WO2001018052A1 (en) 2001-03-15
HUP0202793A3 (en) 2005-07-28
US6800606B1 (en) 2004-10-05
BR0013840A (pt) 2002-07-02
AU7430500A (en) 2001-04-10
CN1287124A (zh) 2001-03-14
CZ20021227A3 (cs) 2002-07-17
CN1125081C (zh) 2003-10-22
EP1210369A1 (en) 2002-06-05
CA2383638A1 (en) 2001-03-15
NO20021135D0 (no) 2002-03-07
HUP0202793A2 (hu) 2002-12-28
JP2003525867A (ja) 2003-09-02

Similar Documents

Publication Publication Date Title
DE60024988D1 (de) Herstellung von therapeutischem mikroschaum
DE60032256D1 (de) Verbesserte sichtbarkeit medizinischer implantate
EE200100370A (et) Teraapias kasutatavad spirofuropüridiinide uued aralküülamiinid
DK1223997T3 (da) Medicinsk infusionssæt
FI972292A0 (fi) Administrering av diabetes
DE69829554D1 (de) Ovalgefortme herzkanüle
DE60011853D1 (de) Injektionsspritze
DE60014279D1 (de) Stiftförmige Medikamentenspritze
DE60039643D1 (de) Herzfrequenz-Überwachungsgerät
NO20022087L (no) Fremgangsmåte for behandling av diabetes
DE60019960D1 (de) Herstellung von isobutencopolymere
EE200100623A (et) Melatoniini terapeutiline kasutamine
NO20021135L (no) Monomere analoger av human insulin
NO20020784D0 (no) Medikament for behandling av brudd
DE29901788U1 (de) Pulsmeßgerät
DK1351697T3 (da) Lægemiddel til fremme af regenerationen af væv
GB9910865D0 (en) Improvements relating to medical syringes
PT1226837E (pt) Coracao artificial ortotopico total
NO20014845D0 (no) Anvendelse av arylalkanoylpyridaziner
DE60017741D1 (de) Medizinisches implantat
DE60037197D1 (de) Verwendung funktioneller oraler präparate
FI4860U1 (fi) Reaktorin sydän
UA33799A (uk) Спосіб одержання препарату інсуліну пролонгованої дії
BR9703132A (pt) Temporizador medicinal
UA3350S (uk) Упакування медичного препарату

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application